Additionally, the FTO level in PCa patients at TNM stage I+ II was higher than that in patients at TNM stage III+IV (Figure 2c), and patients with low FTO expression had a high tendency to suffer lymph node metastasis, which was further confirmed by bioinformatics websites (Figure 2d). This evidence concerns the gene FTO and metastatic malignant neoplasm in the lymph nodes.